This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
VISION Trial
Treatment Considerations in the First Line Setting of mCRPC
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Clinical Trials
From the Editor
Search Clinical Trials
Transformative Trials
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
RSNA 2022
SUO 2022
Urologists for Social Responsibility 2023
Upcoming
ASCO GU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
The International Kidney Cancer Symposium (IKCS) 2022: North America
Viewing 21-40 of 47 articles
IKCS 2022: Collecting Duct, Sarcomatoid, and Rhabdoid Subtypes of Renal Cell Carcinoma
IKCS 2022: Biomarkers of Disease Burden and Treatment Response in Renal Medullary Carcinoma
IKCS 2022: Circulating Biomarkers in Renal Cell Carcinoma
IKCS 2022: Keynote Lecture: The Trajectory of Immunotherapy in Renal Cell Carcinoma
IKCS 2022: Translocation Type Subtypes of Renal Cell Carcinoma
IKCS 2022: Spatial Molecular Imaging to Profile the Epithelial to Mesenchymal Transition and Immune Crosstalk in Sarcomatoid Renal Cell Carcinoma
IKCS 2022: Multidisciplinary Management of Renal Medullary Cancer
IKCS 2022: Association Between Depth of Response (DepOR) and Clinical Outcomes: Exploratory Analysis in Patients with Previously Untreated Advanced Renal Cell Carcinoma (aRCC) in CheckMate 9ER
IKCS 2022: The Patient Perspective on Side-effects and Care
IKCS 2022: The Professional State of Renal Cell Carcinoma
IKCS 2022: Outcomes of Active Surveillance for Young and Healthy Patients with Small Renal Masses
IKCS 2022: Long-Term PFS from TIVO-3: Tivozanib (TIVO) vs Sorafenib (SOR) in Relapsed/refractory (R/R) Advanced RCC
IKCS 2022: APART – a Phase 2 Trial of Axitinib, Palbociclib and Avelumab as Advanced Clear Cell Renal Cell Carcinoma (ccRCC) Therapy
IKCS 2022: Session 2 Debate: Adjuvant or Not?
IKCS 2022: Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
IKCS 2022: Session 1 Debate: Surveillance vs. Intervention
IKCS 2022: A Phase II Study of Lenvatinib plus Everolimus Versus Cabozantinib in Patients with Metastatic Renal Cell Carcinoma (mRCC) That Progressed on a PD-1/PD-L1 Checkpoint Inhibitor (LenCabo)
IKCS 2022: A Randomized Trial of Radium-223 (Ra-223) Dichloride and Cabozantinib in Patients (Pts) with Advanced Renal Cell Carcinoma (RCC) with Bone Metastases (RADICAL / Alliance A031801)
IKCS 2022: Phase 2 Trial for Sequential Treatment after Cabozantinib Progression in Metastatic Renal Cell Carcinoma (Seq-Cabo)
IKCS 2022: Characterization of Patients Undergoing Consolidative Nephrectomy after Immunotherapy
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free
